Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 6Phase 1/2 3Phase NA 1Phase 2/3 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 129INDUSTRY 116NIH 19NETWORK 5UNKNOWN 3OTHER_GOV 2

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Tumor-Agnostic 1

Conditions

Esophageal Neoplasms 2Carcinoma, Squamous Cell 1Adenocarcinoma 1

Interventions

Paclitaxel 3S 1 (combination) 2Oxaliplatin 2Irinotecan 2Cisplatin 2Capecitabine 2titanium silicide 1nedaplatin 1anlotinib 1Radiation 1Pemetrexed 1Lenalidomide 1HMPL-013 1Gemcitabine 1Esophagectomy 1Clinical Trials, Phase II as Topic 1Clinical Trials, Phase I as Topic 1Carboplatin 1Bevacizumab 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × UNKNOWN × Paclitaxel × Clear all
NCT03636685 2018-08-17

Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC

ChineseAMS

Phase 1/2 Unknown
60 enrolled
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Squamous Cell

NCT02446574 2017-10-24

Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell Carcinoma

ChineseAMS

Phase 1/2 Completed
33 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT02429622 2017-01-18

Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma

ChineseAMS

Phase 1/2 Completed
80 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡